Learn about the latest advancements in immunotherapy research focusing on harnessing IL-12 for the treatment of ovarian cancer to potentially improve survival rates.

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased by an experimental non-hormonal drug being developed by Bayer , according ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.

PDS Biotechnology has completed subject recruitment for stage 1 of its Phase II trial, evaluating the systemic administration of PDS01ADC.

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

ImmunityBio, Inc. (NASDAQ: IBRX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...

Three Democratic-led states that offered free health care to low-income people who are in the U.S. without legal permission ...

A new immunotherapy trial to treat the deadliest form of brain cancer is seeking patients after one man had remarkable results that saw his tumour vanish. The NHS study will recruit 16 people over an ...

Health bodies have called for investment in these ‘essential components of cancer care’ so they do not become ‘optional extras’, ...

At least two dozen bills have been introduced across 15 states this year. Most of the legislation is related to ...

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...